[go: up one dir, main page]

AU2001280911A1 - Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10 - Google Patents

Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10

Info

Publication number
AU2001280911A1
AU2001280911A1 AU2001280911A AU8091101A AU2001280911A1 AU 2001280911 A1 AU2001280911 A1 AU 2001280911A1 AU 2001280911 A AU2001280911 A AU 2001280911A AU 8091101 A AU8091101 A AU 8091101A AU 2001280911 A1 AU2001280911 A1 AU 2001280911A1
Authority
AU
Australia
Prior art keywords
encoded
cytomegalovirus encoded
rhesus
immunologic activities
cytomegalovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280911A
Other languages
English (en)
Inventor
Mark Penfold
Thomas J. Schall
Juliet Spencer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemocentryx Inc
Original Assignee
Chemocentryx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemocentryx Inc filed Critical Chemocentryx Inc
Publication of AU2001280911A1 publication Critical patent/AU2001280911A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2066IL-10
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001280911A 2000-07-28 2001-07-30 Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10 Abandoned AU2001280911A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22183100P 2000-07-28 2000-07-28
US60221831 2000-07-28
PCT/US2001/023942 WO2002032457A1 (fr) 2000-07-28 2001-07-30 Activites immunologiques du cytomegalovirus de rhesus code il-10 et du cytomegalovirus humain code il-10

Publications (1)

Publication Number Publication Date
AU2001280911A1 true AU2001280911A1 (en) 2002-04-29

Family

ID=22829580

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280911A Abandoned AU2001280911A1 (en) 2000-07-28 2001-07-30 Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10

Country Status (4)

Country Link
US (2) US20020197234A1 (fr)
EP (1) EP1307228A4 (fr)
AU (1) AU2001280911A1 (fr)
WO (1) WO2002032457A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050281885A1 (en) * 2004-06-21 2005-12-22 Egilmez Nejat K Method for treating inflammatory bowel disease by oral administration of IL-10
EP4582440A3 (fr) * 2018-12-21 2025-10-08 The Regents of the University of California Vaccins contenant il-10 et leurs utilisations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827513A (en) * 1990-06-29 1998-10-27 Schering Corporation Methods of treating insulin-dependent diabetes mellitus by administration of IL-10
US5833976A (en) * 1991-08-06 1998-11-10 Schering Corporation Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity
US5368854A (en) * 1992-08-20 1994-11-29 Schering Corporation Use of IL-10 to treat inflammatory bowel disease
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
TW381026B (en) * 1993-01-13 2000-02-01 Schering Corp Method of extracorporally activating cytolytic activity of peripheral blood mononuclear cells and pharmaceutical composition comprising the activated peripheral blood mononuclear cells
US5866134A (en) * 1995-03-24 1999-02-02 Schering Corporation Method for enhancing the antibody response to specific antigens with Interleukin-10
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
AU7346100A (en) * 1999-09-02 2001-03-26 University Of Medicine And Dentistry Of New Jersey Cytomegalovirus-encoded il-10 homolog

Also Published As

Publication number Publication date
US20050191274A1 (en) 2005-09-01
EP1307228A1 (fr) 2003-05-07
WO2002032457A1 (fr) 2002-04-25
EP1307228A4 (fr) 2005-05-18
US20020197234A1 (en) 2002-12-26

Similar Documents

Publication Publication Date Title
AU2002323210A1 (en) Bio-synthetic photostimulators and methods of use
AU2001286171A1 (en) Human cDNAs and proteins and uses thereof
AU2002306768A1 (en) Expression profiles and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2001227751A1 (en) Thermal joint and method of use
AU2003288902A1 (en) Microcapsules and methods of use
AU2003226152A1 (en) Multifunctional flavor systems and method of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002335085A1 (en) Angiopoietins and methods of use thereof
AU2002359512A1 (en) Belts and methods of use thereof
AU2002213355A1 (en) Wireless asp systems and methods
AUPR301001A0 (en) Compression garments and methods of use
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002338655A1 (en) Methods of preparing sulfinamide and sulfoxides
AU2003245487A1 (en) Cosmetic appliance and method of use
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2001249567A1 (en) Shaped springs and methods of fabricating and using shaped springs
AU2002310237A1 (en) Sponge-derived terpenoids and methods of use
AU2001280911A1 (en) Immunologic activities of rhesus cytomegalovirus encoded il-10 and human cytomegalovirus encoded il-10
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001233588A1 (en) New toralactone and its derivation and the use of decreasing blood-fat and losing weight
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2003274919A1 (en) Multifunctional context-activated protides and methods of use